The primary efficacy outcome , survival at 12 months after cardiac arrest with a Vineland Adaptive Behavior Scales , second edition ( VABS-II ) , score of 70 or higher ( on a scale from 20 to 160 , with higher scores indicating better function ) , was evaluated among patients with a VABS-II score of at least 70 before cardiac arrest .